| 1 | [SID862610] | Active | IC50 | 0.2801 | Tumor Hsp90 Inhibitors Dose Response Confirmation [AID712, Type: confirmatory] | 90-kda heat shock protein beta HSP90 beta [Homo sapiens] [gi:4261762] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | IC50 | 0.2801 [uM] | | BioAssay | Tumor Hsp90 Inhibitors Dose Response Confirmation | | AID | 712 | | BioAssay type | confirmatory | | Target | 90-kda heat shock protein beta HSP90 beta [Homo sapiens] [gi:4261762] | | PubMed | | | Data Table |  |
|
| 2 | [SID862610] | Active | EC50 | 0.5489 | Fluorescence Polarization Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of the LANA Histone H2A/H2B Interaction [AID435023, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | EC50 | 0.5489 [uM] | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 435023 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|
| 3 | [SID862610] | Active | Potency | 0.631 | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore) [AID892, Type: confirmatory] | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 0.631 [uM] | | BioAssay | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore) | | AID | 892 | | BioAssay type | confirmatory | | Target | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] | | PubMed | | | Data Table |  |
|
| 4 | [SID862610] | Active | Potency | 0.7943 | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore) [AID875, Type: confirmatory] | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 0.7943 [uM] | | BioAssay | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore) | | AID | 875 | | BioAssay type | confirmatory | | Target | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] | | PubMed | | | Data Table |  |
|
| 5 | [SID862610] | Active | EC50 | 1.11 | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W. [AID1330, Type: confirmatory] | Bcl-w [Homo sapiens] [gi:1572493] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | EC50 | 1.11 [uM] | | BioAssay | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W. | | AID | 1330 | | BioAssay type | confirmatory | | Target | Bcl-w [Homo sapiens] [gi:1572493] | | PubMed | | | Data Table |  |
|
| 6 | [SID862610] | Active | EC50 | 1.11 | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W. [AID1330, Type: confirmatory] | Bcl-w [Homo sapiens] [gi:1572493] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | EC50 | 1.11 [uM] | | BioAssay | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W. | | AID | 1330 | | BioAssay type | confirmatory | | Target | Bcl-w [Homo sapiens] [gi:1572493] | | PubMed | | | Data Table |  |
|
| 7 | [SID862610] | Active | EC50 | 1.14 | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL. [AID1322, Type: confirmatory] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | EC50 | 1.14 [uM] | | BioAssay | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL. | | AID | 1322 | | BioAssay type | confirmatory | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 8 | [SID862610] | Active | EC50 | 1.14 | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL. [AID1322, Type: confirmatory] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | EC50 | 1.14 [uM] | | BioAssay | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL. | | AID | 1322 | | BioAssay type | confirmatory | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 9 | [SID862610] | Active | EC50 | 1.14 | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL. [AID1322, Type: confirmatory] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | EC50 | 1.14 [uM] | | BioAssay | Multiplexed dose response screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL. | | AID | 1322 | | BioAssay type | confirmatory | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 10 | [SID862610] | Active | IC50 | 1.19 | MKP-3 in vitro HTS assay [AID425, Type: confirmatory] | dual specificity protein phosphatase 6 [Rattus norvegicus] [gi:16758752] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | IC50 | 1.19 [uM] | | BioAssay | MKP-3 in vitro HTS assay | | AID | 425 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 6 [Rattus norvegicus] [gi:16758752] | | PubMed | | | Data Table |  |
|
| 11 | [SID862610] | Active | IC50 | 1.19 | MKP-3 in vitro HTS assay [AID425, Type: confirmatory] | dual specificity protein phosphatase 6 [Rattus norvegicus] [gi:16758752] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | IC50 | 1.19 [uM] | | BioAssay | MKP-3 in vitro HTS assay | | AID | 425 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 6 [Rattus norvegicus] [gi:16758752] | | PubMed | | | Data Table |  |
|
| 12 | [SID862610] | Active | IC50 | 1.717 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID2754, Type: confirmatory] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | IC50 | 1.717 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 2754 | | BioAssay type | confirmatory | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 13 | [SID862610] | Active | IC50 | 1.717 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID2754, Type: confirmatory] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | IC50 | 1.717 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 2754 | | BioAssay type | confirmatory | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 14 | [SID862610] | Active | Potency | 2.21 | Beta amyloid ThS binding assay [AID956, Type: confirmatory] | beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-b [gi:257056] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 2.21 [uM] | | BioAssay | Beta amyloid ThS binding assay | | AID | 956 | | BioAssay type | confirmatory | | Target | beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-b [gi:257056] | | PubMed | | | Data Table |  |
|
| 15 | [SID862610] | Active | IC50 | 3.019 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput counterscreen to identify inhibitors of TEM-1 metallo-beta-lactamase [AID2755, Type: confirmatory] | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | IC50 | 3.019 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput counterscreen to identify inhibitors of TEM-1 metallo-beta-lactamase | | AID | 2755 | | BioAssay type | confirmatory | | Target | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] | | PubMed | | | Data Table |  |
|
| 16 | [SID862610] | Active | Potency | 3.15137 | Alpha-synuclein ThS binding assay [AID937, Type: confirmatory] | alpha synuclein [Homo sapiens] [gi:46242542] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 3.15137 [uM] | | BioAssay | Alpha-synuclein ThS binding assay | | AID | 937 | | BioAssay type | confirmatory | | Target | alpha synuclein [Homo sapiens] [gi:46242542] | | PubMed | | | Data Table |  |
|
| 17 | [SID862610] | Active | Potency | 3.15137 | Alpha-synuclein ThS binding assay [AID937, Type: confirmatory] | alpha synuclein [Homo sapiens] [gi:46242542] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 3.15137 [uM] | | BioAssay | Alpha-synuclein ThS binding assay | | AID | 937 | | BioAssay type | confirmatory | | Target | alpha synuclein [Homo sapiens] [gi:46242542] | | PubMed | | | Data Table |  |
|
| 18 | [SID862610] | Active | IC50 | 3.18 | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2073, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | IC50 | 3.18 [uM] | | BioAssay | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay | | AID | 2073 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 19 | [SID862610] | Active | EC50 | 4.05 | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2 [AID1328, Type: confirmatory] | Apoptosis regulator Bcl- [gi:231632] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | EC50 | 4.05 [uM] | | BioAssay | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2 | | AID | 1328 | | BioAssay type | confirmatory | | Target | Apoptosis regulator Bcl- [gi:231632] | | PubMed | | | Data Table |  |
|
| 20 | [SID862610] | Active | EC50 | 4.05 | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2 [AID1328, Type: confirmatory] | Apoptosis regulator Bcl- [gi:231632] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | EC50 | 4.05 [uM] | | BioAssay | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2 | | AID | 1328 | | BioAssay type | confirmatory | | Target | Apoptosis regulator Bcl- [gi:231632] | | PubMed | | | Data Table |  |
|
| 21 | [SID862610] | Active | IC50 | 5.385 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1metallo-beta-lactamase [AID2756, Type: confirmatory] | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | IC50 | 5.385 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1metallo-beta-lactamase | | AID | 2756 | | BioAssay type | confirmatory | | Target | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] | | PubMed | | | Data Table |  |
|
| 22 | [SID862610] | Active | Potency | 5.51 | Tau ThS binding assay [AID911, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 5.51 [uM] | | BioAssay | Tau ThS binding assay | | AID | 911 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 23 | [SID862610] | Active | Potency | 5.51 | Tau ThS binding assay [AID911, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 5.51 [uM] | | BioAssay | Tau ThS binding assay | | AID | 911 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 24 | [SID862610] | Active | EC50 | 8.025 | Luminescence Cell-Free Homogenous Dose Retest to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2821, Type: confirmatory] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | EC50 | 8.025 [uM] | | BioAssay | Luminescence Cell-Free Homogenous Dose Retest to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2821 | | BioAssay type | confirmatory | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 25 | [SID862610] | Active | EC50 | 8.025 | Luminescence Cell-Free Homogenous Dose Retest to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2821, Type: confirmatory] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | EC50 | 8.025 [uM] | | BioAssay | Luminescence Cell-Free Homogenous Dose Retest to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2821 | | BioAssay type | confirmatory | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 26 | [SID862610] | Active | EC50 | 8.025 | Luminescence Cell-Free Homogenous Dose Retest to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2821, Type: confirmatory] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | EC50 | 8.025 [uM] | | BioAssay | Luminescence Cell-Free Homogenous Dose Retest to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2821 | | BioAssay type | confirmatory | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 27 | [SID862610] | Active | Potency | 11.2202 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 28 | [SID862610] | Active | Potency | 11.2202 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 29 | [SID862610] | Active | Potency | 12.5893 | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID862610] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID862610] | Active | Potency | 12.5893 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 32 | [SID862610] | Active | Potency | 13.1154 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 13.1154 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID862610] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 34 | [SID862610] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 35 | [SID862610] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 36 | [SID862610] | Active | Potency | 14.581 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 37 | [SID862610] | Active | Potency | 15.8489 | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 38 | [SID862610] | Active | Potency | 15.8489 | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 39 | [SID862610] | Active | Potency | 15.8489 | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 40 | [SID862610] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 41 | [SID862610] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 42 | [SID862610] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table |  |
|
| 43 | [SID862610] | Active | Potency | 15.8489 | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 44 | [SID862610] | Active | Potency | 19.9526 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 45 | [SID862610] | Active | Potency | 19.9526 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 46 | [SID862610] | Active | Potency | 19.9526 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 47 | [SID862610] | Active | Potency | 19.9526 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 48 | [SID862610] | Active | Potency | 19.9526 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 49 | [SID862610] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 50 | [SID862610] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 862610 | | CID | 663844 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|